Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial
抗腺病毒抗体可预测对卡介苗无反应的非肌层浸润性膀胱癌患者接受纳多法拉根菲拉德诺韦克治疗的疗效持久性：一项3期临床试验的二次分析
期刊:
影响因子:
doi:10.1016/j.eururo.2021.12.009
Mitra, Anirban P; Narayan, Vikram M; Mokkapati, Sharada; Miest, Tanner; Boorjian, Stephen A; Alemozaffar, Mehrdad; Konety, Badrinath R; Shore, Neal D; Gomella, Leonard G; Kamat, Ashish M; Bivalacqua, Trinity J; Montgomery, Jeffrey S; Lerner, Seth P; Busby, J Erik; Poch, Michael; Crispen, Paul L; Steinberg, Gary D; Schuckman, Anne K; Downs, Tracy M; Svatek, Robert S; Mashni, Joseph; Lane, Brian R; Guzzo, Thomas J; Bratslavsky, Gennady; Karsh, Lawrence I; Woods, Michael E; Brown, Gordon A; Canter, Daniel; Luchey, Adam; Lotan, Yair; Krupski, Tracey; Inman, Brant A; Williams, Michael B; Cookson, Michael S; Keegan, Kirk A; Andriole, Gerald L; Sankin, Alexander I; Boyd, Alan; O'Donnell, Michael A; Philipson, Richard; Ylä-Herttuala, Seppo; Sawutz, David; Parker, Nigel R; McConkey, David J; Dinney, Colin P N
